ASH Launches Research Collaborative COVID-19 Registry
June 5, 2020 – The American Society of Hematology (ASH) recently created a Research Collaborative (RC) COVID-19 Registry to collect de-identified data on patients with a positive COVID-19 diagnosis and a hematologic malignancy. This global Registry has now been expanded to accept data for COVID-19 patients with ANY hematologic condition, including thalassemia.
Healthcare providers can enter patient data into this Registry via a data collection tool on the ASH Research Collaborative website at: https://www.ashresearchcollaborative.org/s/covid-19-registry
The data from this effort are analyzed on an ongoing basis and made available on a public dashboard at: https://www.ashresearchcollaborative.org/s/covid-19-registry-data-summaries